戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 and an internal fragment of an NRAMP gene in Burkholderia cepacia.
2 and in the use of a prolonged incubation for Burkholderia cepacia.
3 is and other species, including (cultivable) Burkholderia cepacia.
4 bors, such as Burkholderia thailandensis and Burkholderia cepacia.
5 olysis of anchovy oil with lipase PS-DI from Burkholderia cepacia.
6 oteobacteria including a clinical isolate of Burkholderia cepacia.
7 ise bacteria previously identified merely as Burkholderia cepacia.
8                                 Clearance of Burkholderia cepacia, a major pathogen in CGD, was reduc
9                                              Burkholderia cepacia AC1100 completely degrades 2,4,5-tr
10                                              Burkholderia cepacia AC1100 metabolizes 2,4,5-trichlorop
11                                              Burkholderia cepacia AC1100 uses 2,4,5-trichlorophenoxya
12 ptional activation by insertion sequences in Burkholderia cepacia AC1100 were investigated.
13 ying a suspension of immobilized lipase from Burkholderia cepacia (Amano PS-IM) in a mixture of vinyl
14 ont Rhizobium NGR234 and the root-colonizing Burkholderia cepacia AMMD, conferred to Escherichia coli
15 cretion genes in the gram-negative bacterium Burkholderia cepacia, an important pulmonary pathogen in
16 MN(+) mice survived after being administered Burkholderia cepacia, an opportunistic pathogen in CGD p
17 ese reactive species in host defense against Burkholderia cepacia and Chromobacterium violaceum, orga
18             Protocatechuate dioxygenase from Burkholderia cepacia and the substrate, protocatechuate,
19 as aeruginosa, Stenotrophomonas maltophilia, Burkholderia cepacia, and Acinetobacter baumannii.
20 gative pathogens, including Yersinia pestis, Burkholderia cepacia, and Acinetobacter haemolyticus, sy
21                                       Youth, Burkholderia cepacia, and cystic fibrosis-related arthro
22 s of IS285 from Yersinia pestis, IS1356 from Burkholderia cepacia, and ISRm3 from Rhizobium meliloti.
23  late isolates of Pseudomonas aeruginosa and Burkholderia cepacia are associated with differences in
24 monas aeruginosa, Staphylococcus aureus, and Burkholderia cepacia, are known contributors.
25 ipase B) and Amano Lipase PS-C1 (lipase from Burkholderia cepacia) as biocatalysts.
26 ase for phthalate transport, was cloned from Burkholderia cepacia ATCC 17616.
27 ueous Pb(II) sorbed at the interface between Burkholderia cepacia biofilms and hematite (alpha-Fe(2)O
28  during apoptosis induced by phagocytosis of Burkholderia cepacia, Borrelia hermsii, Listeria monocyt
29 spp., Ralstonia spp., Burkholderia gladioli, Burkholderia cepacia, Burkholderia thailandensis, and Ps
30                     In HAECs, PAO1, PAK, and Burkholderia cepacia, but not flagellin-deficient strain
31 rbaspirillum species can be misidentified as Burkholderia cepacia by commercially available microbial
32 n the pathogenesis of respiratory disease in Burkholderia cepacia-colonized cystic fibrosis (CF) pati
33 ost described the use of selective media for Burkholderia cepacia complex (99%), Staphylococcus aureu
34                                              Burkholderia cepacia complex (Bcc) are a group of multid
35                               Strains of the Burkholderia cepacia complex (Bcc) are Gram-negative opp
36                Gram-negative bacteria of the Burkholderia cepacia complex (Bcc) are opportunistic pat
37                          The localization of Burkholderia cepacia complex (Bcc) bacteria in cystic fi
38                              Among them, the Burkholderia cepacia complex (Bcc) bacteria, consisting
39                                          The Burkholderia cepacia complex (BCC) can cause severe lung
40                               Members of the Burkholderia cepacia complex (Bcc) cause considerable mo
41                                          The Burkholderia cepacia complex (Bcc) consists of several s
42                                              Burkholderia cepacia complex (Bcc) has caused healthcare
43                   Several species within the Burkholderia cepacia complex (BCC) have emerged as signi
44                          Biofilm cultures of Burkholderia cepacia complex (BCC) infection have been f
45                                          The Burkholderia cepacia complex (Bcc) is a family of closel
46                                          The Burkholderia cepacia complex (BCC) is a group of Gram-ne
47                                          The Burkholderia cepacia complex (BCC) is a group of Gram-ne
48                                          The Burkholderia cepacia complex (BCC) is known for causing
49 Antimicrobial susceptibility testing for the Burkholderia cepacia complex (BCC) is often used to dete
50 oacae, Stenotrophomonas maltophilia, and the Burkholderia cepacia complex (BCC) may be able to produc
51                   Pseudomonas aeruginosa and Burkholderia cepacia complex (Bcc) species are opportuni
52  cystic fibrosis (CF), airway infection with Burkholderia cepacia complex (Bcc) species or Burkholder
53 undred thirty-eight clinical isolates of the Burkholderia cepacia complex (Bcc) were identified using
54                                              Burkholderia cepacia complex (Bcc), a betaproteobacteria
55 terization of the opportunistic pathogens of Burkholderia cepacia complex (BCC), a group composed of
56                                              Burkholderia cepacia complex and Burkholderia pseudomall
57                "Cepacia syndrome", caused by Burkholderia cepacia complex and often associated with c
58                            Bacteria from the Burkholderia cepacia complex are generally considered to
59                           Organisms from the Burkholderia cepacia complex are important pathogens in
60                       However, patients with Burkholderia cepacia complex are often excluded from tra
61                       Chronic infection with Burkholderia cepacia complex bacteria in cystic fibrosis
62 sential plasmid associated with virulence in Burkholderia cepacia complex bacteria.
63 initive identification of the species in the Burkholderia cepacia complex by routine clinical microbi
64                               Species of the Burkholderia cepacia complex cause chronic and life-thre
65                              Bacteria of the Burkholderia cepacia complex consist of five discrete ge
66 fe threatening infection with species of the Burkholderia cepacia complex frequently occurs as a resu
67 or the rapid detection and identification of Burkholderia cepacia complex genomovars directly from sp
68 n >500 ug/L), and for a lung transplant 6.3 (Burkholderia cepacia complex infection for 1 y or less).
69                                              Burkholderia cepacia complex infections contribute signi
70 t pathogens that account for the majority of Burkholderia cepacia complex infections in cystic fibros
71                                          The Burkholderia cepacia complex is a group of Burkholderia
72                                              Burkholderia cepacia complex is a group of potential nos
73      Misidentification of A. xylosoxidans as Burkholderia cepacia complex is especially problematic a
74                                  We analyzed Burkholderia cepacia complex isolates recovered from 1,2
75 r relative levels of accuracy in identifying Burkholderia cepacia complex isolates recovered from cys
76        Our understanding of the virulence of Burkholderia cepacia complex lung infections in cystic f
77    PCR primers targeting loci in the current Burkholderia cepacia complex multilocus sequence typing
78    Pseudomonas aeruginosa and members of the Burkholderia cepacia complex often coexist in both the s
79 y related to, and commonly misidentified as, Burkholderia cepacia complex or Ralstonia species.
80 thods is difficult, and differentiation from Burkholderia cepacia complex organisms may be especially
81                        Over a 6-year period, Burkholderia cepacia complex species were isolated from
82 n of only 44% of the genes between LB400 and Burkholderia cepacia complex strain 383.
83 rosis (CF) patients including members of the Burkholderia cepacia complex that cause a high rate of m
84 ted from biofilms produced by species of the Burkholderia cepacia complex were shown to possess clust
85 i complex, Stenotrophomonas maltophilia, and Burkholderia cepacia complex were tested.
86                   It is also a member of the Burkholderia cepacia complex, a group of closely related
87 ia cenocepacia is an important member of the Burkholderia cepacia complex, a group of closely related
88 s species and closely related species in the Burkholderia cepacia complex, accurate identification is
89 elective media designed for the isolation of Burkholderia cepacia complex, along with two media desig
90                                   Within the Burkholderia cepacia complex, B. cenocepacia is the most
91 epacia strain K56-2, a representative of the Burkholderia cepacia complex, is part of the epidemic an
92 ortunistic pathogens, such as members of the Burkholderia cepacia complex, likewise display elevated
93 LIs with a focus on clinical utility against Burkholderia cepacia complex, Stenotrophomonas maltophil
94  Gram-negative bacterium and a member of the Burkholderia cepacia complex, which is frequently associ
95 ars I, III, and IV) currently constitute the Burkholderia cepacia complex.
96  to identify species (genomovars) within the Burkholderia cepacia complex.
97 ptible to life-threatening infections by the Burkholderia cepacia complex.
98  were initially identified as members of the Burkholderia cepacia complex.
99 cep781, whose hosts are soil isolates of the Burkholderia cepacia complex.
100                                              Burkholderia cepacia DBO1 is able to utilize phthalate a
101                       A gene was cloned from Burkholderia cepacia DBO1 that is homologous with Escher
102  enzymes needed for phthalate degradation by Burkholderia cepacia DBO1.
103 We investigated the utility of PCR to detect Burkholderia cepacia directly in sputum samples at two c
104 more active than other tetracyclines against Burkholderia cepacia, Escherichia coli, Serratia marcesc
105 on of the related toluene o-monooxygenase of Burkholderia cepacia G4 and a previously reported T4MO G
106 vity of toluene ortho-monooxygenase (TOM) of Burkholderia cepacia G4 for both chlorinated ethenes and
107 ion and toluene ortho-monooxygenase (TOM) of Burkholderia cepacia G4 hydroxylates at the ortho positi
108                 Toluene 2-monooxygenase from Burkholderia cepacia G4 is implicated in trichloroethyle
109 alyzed a collection of 97 well-characterized Burkholderia cepacia genomovar III isolates to evaluate
110                                              Burkholderia cepacia has emerged as a serious respirator
111                                              Burkholderia cepacia has emerged as an important pulmona
112                                              Burkholderia cepacia has recently been recognized as an
113                                              Burkholderia cepacia infection decreased survival, regar
114 model leading to complete protection against Burkholderia cepacia infection, and restored healthy don
115                                              Burkholderia cepacia is an emerging opportunistic pathog
116                                              Burkholderia cepacia is an important opportunistic human
117                                              Burkholderia cepacia is an important pathogen in cystic
118                                              Burkholderia cepacia is an opportunistic pathogen that h
119                                         More Burkholderia cepacia isolates (P < 0.01), Candida albica
120 phan catabolic pathway is characterized from Burkholderia cepacia J2315.
121  canned food's oil fraction by the action of Burkholderia cepacia lipase.
122 t some other nonfermentative bacilli such as Burkholderia cepacia (MIC(90), >/=128 microg/ml).
123 ), Stenotrophomonas maltophilia (n = 1), and Burkholderia cepacia (n = 1).
124 egorize patients into panresistant (n = 27) (Burkholderia cepacia, n = 6, and Pseudomonas aeruginosa,
125                 Recurrence of infection with Burkholderia cepacia or Serratia marcescens was caused b
126                           We experienced two Burkholderia cepacia outbreaks over a 1-year period.
127 ied within a 27-kb region of DNA cloned from Burkholderia cepacia R34, a strain that grows using 2,4-
128 oblematic, and analysis of isolates from the Burkholderia cepacia Research Laboratory and Repository
129 ng a panel of 102 isolates obtained from the Burkholderia cepacia Research Laboratory and Repository.
130 ferredoxins (the Thermus Rieske protein, the Burkholderia cepacia Rieske-type biphenyl dioxygenase fe
131 veral clinical and environmental isolates of Burkholderia cepacia secreted ATP-utilizing enzymes to t
132 m of this study was to compare RGM medium to Burkholderia cepacia selective agar (BCSA) and a standar
133 ients with CF by extending incubation of the Burkholderia cepacia selective agar (BCSA) from 5 to 14
134                       Extended incubation on Burkholderia cepacia selective agar (BCSA) has been reco
135  subspecies level, from Middlebrook 7H11 and Burkholderia cepacia selective agars.
136                                              Burkholderia cepacia sepsis/pneumonia was the second mos
137 dation of tryptophan through anthranilate by Burkholderia cepacia, several plasposon mutations were c
138 ung disease including Staphylococcal aureus, Burkholderia cepacia, Stenotrophomonas maltophilia, Achr
139 led tobramycin did not increase isolation of Burkholderia cepacia, Stenotrophomonas maltophilia, or A
140 y reviewing isolates initially identified as Burkholderia cepacia susceptible to all antibiotics test
141  but was less sensitive for the detection of Burkholderia cepacia than the standard method.
142                                              Burkholderia cepacia was isolated from 3 of [corrected]
143 rgillus fumigatus, Staphylococcus aureus, or Burkholderia cepacia were compared in wild-type, X-CGD m
144                          The final case grew Burkholderia cepacia, which was not grown in the sputum.
145  incubated with P. aeruginosa strain PAK and Burkholderia cepacia, while little activation was observ

 
Page Top